Active Ingredients and Mechanism of Gegen Qinlian Decoction in the Treatment of Diabetic Cardiomyopathy: A Network Pharmacology Study

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2024 Aug 13

PMID 39136516

Authors

Min Wang

Yanbin Liang

Yuce Qin

Ruimian Ma

Huanting Yu

Weixue Wang

Xiaoxi Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic cardiomyopathy (DCM) is a common diabetes complication with limited medications. Gegen Qinlian decoction (GQD) has been used in the treatment of diabetes and its related complications in China for several decades.

Objective: In this study, network pharmacology was employed to predict the active ingredients, key targets, and pathways involved in the treatment of DCM by GQD and to validate it by animal experiments.

Methods: The active ingredients of GQD were retrieved from TCMSP and published literature. DCM-related gene targets were searched in Drugbank, Genecards, Disgenet, and OMIM disease databases. Protein-protein interaction networks were constructed using the STRING database and Cytoscape. GO analysis and KEGG pathway enrichment analysis were performed using the Metascape platform. Moreover, a diabetic mouse model was established to evaluate the therapeutic effects of GQD by measuring serum biochemical markers and inflammation levels. Finally, the expression of predicted key target genes was determined using real-time quantitative PCR.

Results: A total of 129 active ingredients were screened from GQD. Moreover, 146 intersecting genes related to DCM were obtained, with key targets, including AKT1, TNF, IL6, and VEGFA. Lipid and atherosclerosis, AGE-RAGE, PI3K-AKT, and MAPK pathways were identified. Blood glucose control, decreased inflammatory factors, and serum CK-MB levels were restored after GQD intervention, and the same occurred with the expressions of PPAR-γ, AKT1, APOB, and GSK3B genes.

Conclusion: Quercetin, kaempferol, wogonin, 7-methoxy-2-methyl isoflavone, and formononetin may exert major therapeutic effects by regulating key factors, such as AKT1, APOB, and GSK3B, in the inflammatory reaction, glycolipid oxidation, and glycogen synthesis related signaling pathways.

References

Reusch J, Manson J . Management of Type 2 Diabetes in 2017: Getting to Goal. JAMA. 2017; 317(10):1015-1016. PMC: 5894353. DOI: 10.1001/jama.2017.0241. View

Mendis S, Davis S, Norrving B . Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015; 46(5):e121-2. DOI: 10.1161/STROKEAHA.115.008097. View

Jia G, Hill M, Sowers J . Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res. 2018; 122(4):624-638. PMC: 5819359. DOI: 10.1161/CIRCRESAHA.117.311586. View

Surguchov A, Bernal L, Surguchev A . Phytochemicals as Regulators of Genes Involved in Synucleinopathies. Biomolecules. 2021; 11(5). PMC: 8145209. DOI: 10.3390/biom11050624. View

Xu Y, Huang J, Wang N, Tan H, Zhang C, Li S . Network Pharmacology-Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction. Front Pharmacol. 2021; 12:649606. PMC: 8350346. DOI: 10.3389/fphar.2021.649606. View

Tong X, Zhao L, Lian F, Zhou Q, Xia L, Zhang J . Clinical observations on the dose-effect relationship of gegen qin lian decoction on 54 out-patients with type 2 diabetes. J Tradit Chin Med. 2011; 31(1):56-9. DOI: 10.1016/s0254-6272(11)60013-7. View

He L, Bao T, Yang Y, Wang H, Gu C, Chen J . Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA. J Ethnopharmacol. 2021; 285:114786. DOI: 10.1016/j.jep.2021.114786. View

Xiong X . [Gegen Qinlian Decoction formula syndrome and its application in diabetes, hypertension, hyperlipidemia and obesity]. Zhongguo Zhong Yao Za Zhi. 2020; 45(12):2760-2764. DOI: 10.19540/j.cnki.cjcmm.20190829.501. View

Boudina S, Abel E . Diabetic cardiomyopathy revisited. Circulation. 2007; 115(25):3213-23. DOI: 10.1161/CIRCULATIONAHA.106.679597. View

10.

Tan Y, Zhang Z, Zheng C, Wintergerst K, Keller B, Cai L . Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020; 17(9):585-607. PMC: 7849055. DOI: 10.1038/s41569-020-0339-2. View

11.

Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z . The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy. Front Immunol. 2022; 13:951381. PMC: 9666770. DOI: 10.3389/fimmu.2022.951381. View

12.

Xu X, Niu L, Liu Y, Pang M, Lu W, Xia C . Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation. J Ethnopharmacol. 2020; 262:113129. DOI: 10.1016/j.jep.2020.113129. View

13.

Liu W, Xiong X, Feng B, Yuan R, Chu F, Liu H . Classic herbal formula Zhigancao Decoction for the treatment of premature ventricular contractions (PVCs): a systematic review of randomized controlled trials. Complement Ther Med. 2015; 23(1):100-15. DOI: 10.1016/j.ctim.2014.12.008. View

14.

Wang N, Zhang J, Xu H, Wang G, Chu L . [Effects of buzhong yiqi decoction on adriamycin induced heart failure in rats]. Zhongguo Zhong Yao Za Zhi. 2011; 36(4):508-10. View

15.

Zhen Z, Chang B, Li M, Lian F, Chen L, Dong L . Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. Am J Chin Med. 2011; 39(1):53-63. DOI: 10.1142/S0192415X11008646. View

16.

Moosavi-Movahedi A, Hakimelahi S, Chamani J, Khodarahmi G, Hassanzadeh F, Luo F . Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity. Bioorg Med Chem. 2003; 11(20):4303-13. DOI: 10.1016/s0968-0896(03)00524-8. View

17.

Kalhori F, Yazdyani H, Khademorezaeian F, Hamzkanloo N, Mokaberi P, Hosseini S . Enzyme activity inhibition properties of new cellulose nanocrystals from Citrus medica L. pericarp: A perspective of cholesterol lowering. Luminescence. 2022; 37(11):1836-1845. DOI: 10.1002/bio.4360. View

18.

Malek-Esfandiari Z, Rezvani-Noghani A, Sohrabi T, Mokaberi P, Amiri-Tehranizadeh Z, Chamani J . Molecular Dynamics and Multi-Spectroscopic of the Interaction Behavior between Bladder Cancer Cells and Calf Thymus DNA with Rebeccamycin: Apoptosis through the Down Regulation of PI3K/AKT Signaling Pathway. J Fluoresc. 2023; 33(4):1537-1557. DOI: 10.1007/s10895-023-03169-4. View

19.

Kabiri M, Amiri-Tehranizadeh Z, Baratian A, Saberi M, Chamani J . Use of spectroscopic, zeta potential and molecular dynamic techniques to study the interaction between human holo-transferrin and two antagonist drugs: comparison of binary and ternary systems. Molecules. 2012; 17(3):3114-47. PMC: 6268275. DOI: 10.3390/molecules17033114. View

20.

Solinas G, Vilcu C, Neels J, Bandyopadhyay G, Luo J, Naugler W . JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007; 6(5):386-97. DOI: 10.1016/j.cmet.2007.09.011. View